Growth Metrics

Organogenesis Holdings (ORGO) Total Current Liabilities (2016 - 2025)

Organogenesis Holdings has reported Total Current Liabilities over the past 10 years, most recently at $100.1 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $100.1 million for Q4 2025, up 29.23% from a year ago — trailing twelve months through Dec 2025 was $100.1 million (up 29.23% YoY), and the annual figure for FY2025 was $100.1 million, up 29.23%.
  • Total Current Liabilities for Q4 2025 was $100.1 million at Organogenesis Holdings, up from $90.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ORGO hit a ceiling of $100.1 million in Q4 2025 and a floor of $65.1 million in Q1 2025.
  • Median Total Current Liabilities over the past 5 years was $80.8 million (2021), compared with a mean of $80.5 million.
  • Biggest five-year swings in Total Current Liabilities: soared 34.99% in 2021 and later decreased 23.2% in 2025.
  • Organogenesis Holdings' Total Current Liabilities stood at $82.7 million in 2021, then dropped by 9.29% to $75.0 million in 2022, then increased by 7.31% to $80.5 million in 2023, then decreased by 3.77% to $77.5 million in 2024, then rose by 29.23% to $100.1 million in 2025.
  • The last three reported values for Total Current Liabilities were $100.1 million (Q4 2025), $90.3 million (Q3 2025), and $65.8 million (Q2 2025) per Business Quant data.